Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by PTBaileyon Apr 28, 2021 9:55am
150 Views
Post# 33081610

RE:Reverse split is a necessity

RE:Reverse split is a necessity
whisky11 wrote: We have a lot of shares and low price.
Most of us if  not all are retail investors. Bad news is more powerful than good one, so the guys like
polygraph46 and DogeCoin are using fake news and misrepresentation to spread mistrust to  the company. 
It doesn't work ,the volume is very low, it's mean that we keep strong and been waiting for phase 1 and beyond.
We should look at the problem this way, we have  almost 600,000,000 shares and the price is below five cents. 
If we keep it the same way I mean a lot of shares and low stock price any longer, the same situation will last forever. Like they're saying if you do things the same way you will have the same affect.
It have to be changed, we have to have retail investors as soon as possible. Consolidation of shares was advised by investment bank and those guys know what they're talking about.



...The definition of insanity is doing the same thing over and over again and expecting a different result. These words are usually credited to the acclaimed genius Albert Einstein...
The definition of insanity is doing the same thing over and over again and expecting a different result. These words are usually credited to the acclaimed genius Albert Einstein.


Thanks for common sense post.

<< Previous
Bullboard Posts
Next >>